Senate Gives Hemp THC Industry a Four-Week Reprieve as House Showdown Looms
The Senate has approved a stopgap funding bill that would delay a federal crackdown on most intoxicating hemp-derived THC products until Dec. 11. The measure gives lawmakers and industry groups roughly four additional weeks to pursue a regulatory alternative, but the delay still faces opposition in the House and does not yet change the Nov. 12 enforcement date.
Key takeaways
-
The Senate voted 90-6 to pass the government funding bill.
-
A 61-32 vote defeated an amendment seeking to preserve the Nov. 12 ban date.
-
Naturally produced hemp cannabinoids, including delta-8 and delta-10 THC, would receive the delay.
-
Synthetic cannabinoids not naturally produced by the hemp plant would remain subject to the Nov. 12 deadline under the Senate language.
-
The House must resolve differences between the two chambers’ funding bills.
What the Senate approved
The hemp provision was included in a continuing resolution designed to fund federal agencies at current levels through Dec. 11, avoiding a potential shutdown after the fiscal year ends Sept. 30. The Senate passed the broader measure shortly before adjourning for its August recess.
The language would postpone implementation of legislation signed last year that narrows the federal definition of hemp. That law would make products containing more than 0.4 milligrams of total THC per container illegal, threatening many gummies, beverages, flower products and other cannabinoid items currently sold outside state-licensed marijuana markets.
Amendment to keep the ban on schedule fails
Sen. Ted Budd, R-N.C., and other lawmakers attempted to remove the delay from the funding bill. Budd argued that intoxicating hemp products are frequently sold in convenience stores and marketed in packaging resembling children’s candy and snacks.
Sen. Amy Klobuchar, D-Minn., moved to table the amendment. She said Congress should use the additional time to create safety standards, age restrictions and other rules rather than allow an abrupt prohibition. The Senate rejected Budd’s amendment 61-32.
Industry and cannabis groups remain divided
Hemp trade groups called the vote an important opportunity to establish a federal framework for testing, labeling, taxation and youth protections. Supporters point to Minnesota, where hemp-derived THC edibles and beverages are available to adults under potency and packaging limits.
The regulated cannabis industry strongly disagrees. Cannabis advocates argue that many hemp THC products contain chemically converted or synthetic cannabinoids and compete with licensed businesses while avoiding comparable testing, taxation and oversight. A coalition of state and territorial attorneys general also urged Congress not to delay the ban, warning that changing course could create regulatory uncertainty and renewed youth-access concerns.
House vote will determine the next step
The House previously passed a funding measure extending agency operations into December without a hemp delay. House lawmakers are expected to address the differences when they return from recess, creating a potential confrontation over whether to preserve the Senate provision.
The White House has supported delaying or revising the ban, while opponents—including Budd—say they will continue fighting to keep the November deadline. Even if the Senate language becomes law, lawmakers would have only a short window to agree on a permanent approach before Dec. 11.
Actionable Steps to Make Your Voice Heard
Conclusion:
The battle over the future of hemp-derived THC has reached a critical junction in Washington. While the Senate's decisive vote to extend the enforcement deadline until December 11 offers a temporary lifeline for naturally produced cannabinoids, the industry is far from safe. With the House pushing back, a tight timeline loom, and the regulated cannabis sector aligning with state attorneys general to enforce the original November 12 ban, the stakes could not be higher for small businesses, farmers, and consumers alike.
